January 22, 2021
The World Health Organization (WHO) plans to approve several COVID-19 vaccines from global manufacturers in coming weeks and months, a document published on Wednesday shows, as it aims for rapid rollouts in poorer countries.
COVAX, a global scheme co-led by the WHO, aims to deliver at least 2 billion COVID-19 doses across the world this year, with at least 1.3 billion doses going to poorer countries.
WHO approval does not automatically lead to purchases by COVAX, but it could facilitate rollout in poorer countries that can acquire the vaccines directly.
So far, two Chinese vaccine makers, Sinopharm and Sinovac, have filed their applications with the WHO. The agency is now reviewing them and could make decisions on both in March at the earliest, the document says.
Pakistan on Monday approved Sinopharm’s COVID-19 vaccine for emergency use, a government statement said, two days after AstraZeneca's vaccine developed with Oxford University received a similar authorization. In addition, Chile approved the emergency use of the Sinovac vaccine on Wednesday.
(Sources: The China Report)
Đăng nhận xét